Intraperitoneal immune cell status in infertile women with and without endometriosis.

Standard

Intraperitoneal immune cell status in infertile women with and without endometriosis. / Tariverdian, N; Siedentopf, F; Rücke, M; Blois, S M; Klapp, B F; Kentenich, H; Arck, Petra.

in: J REPROD IMMUNOL, Jahrgang 80, Nr. 1-2, 1-2, 2009, S. 80-90.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Tariverdian, N, Siedentopf, F, Rücke, M, Blois, SM, Klapp, BF, Kentenich, H & Arck, P 2009, 'Intraperitoneal immune cell status in infertile women with and without endometriosis.', J REPROD IMMUNOL, Jg. 80, Nr. 1-2, 1-2, S. 80-90. https://doi.org/10.1016/j.jri.2008.12.005

APA

Tariverdian, N., Siedentopf, F., Rücke, M., Blois, S. M., Klapp, B. F., Kentenich, H., & Arck, P. (2009). Intraperitoneal immune cell status in infertile women with and without endometriosis. J REPROD IMMUNOL, 80(1-2), 80-90. [1-2]. https://doi.org/10.1016/j.jri.2008.12.005

Vancouver

Tariverdian N, Siedentopf F, Rücke M, Blois SM, Klapp BF, Kentenich H et al. Intraperitoneal immune cell status in infertile women with and without endometriosis. J REPROD IMMUNOL. 2009;80(1-2):80-90. 1-2. https://doi.org/10.1016/j.jri.2008.12.005

Bibtex

@article{e83c0ad30cee4b0e849d16af1afd5abf,
title = "Intraperitoneal immune cell status in infertile women with and without endometriosis.",
abstract = "Endometriosis is a widespread chronic disease characterized by endometrial tissue located outside the uterine cavity. Clinical signs are chronic pelvic pain and infertility. Emerging evidence indicates that the immune system is profoundly involved in the onset and/or progression of endometriosis. However, mechanistic pathways have not yet been conclusively specified. In this study, women undergoing diagnostic laparoscopy due to infertility were recruited, and classified as early-stage endometriosis (n=30), advanced-stage endometriosis (n=8) or no endometriosis (n=31). The frequency and phenotype of leukocytes were evaluated in peritoneal fluid. While the frequency of lymphocytes was not significantly different, neutrophils were increased in endometriosis. Flow cytometry analysis revealed an increased frequency of CD4(+) and CD8(+) cells in peritoneal fluid of endometriosis patients. In addition, the frequency of CD4(+)CD25(+)CD103(+) cells and lineage(-)HLA-DR(+)CD11c(+)CD123(+) dendritic cells was decreased in peritoneal fluid in endometriosis, whereas CD57(+) NK cells and CD8(+)CD28(-) T suppressor cells remained largely unaltered. We conclude that therapeutic approaches in endometriosis might focus on peritoneal leukocytes as a target or surveillance marker; however, immune alterations in peritoneal fluid are subtle and their analysis will require highly standardized and harmonized protocols.",
author = "N Tariverdian and F Siedentopf and M R{\"u}cke and Blois, {S M} and Klapp, {B F} and H Kentenich and Petra Arck",
year = "2009",
doi = "10.1016/j.jri.2008.12.005",
language = "Deutsch",
volume = "80",
pages = "80--90",
journal = "J REPROD IMMUNOL",
issn = "0165-0378",
publisher = "Elsevier Ireland Ltd",
number = "1-2",

}

RIS

TY - JOUR

T1 - Intraperitoneal immune cell status in infertile women with and without endometriosis.

AU - Tariverdian, N

AU - Siedentopf, F

AU - Rücke, M

AU - Blois, S M

AU - Klapp, B F

AU - Kentenich, H

AU - Arck, Petra

PY - 2009

Y1 - 2009

N2 - Endometriosis is a widespread chronic disease characterized by endometrial tissue located outside the uterine cavity. Clinical signs are chronic pelvic pain and infertility. Emerging evidence indicates that the immune system is profoundly involved in the onset and/or progression of endometriosis. However, mechanistic pathways have not yet been conclusively specified. In this study, women undergoing diagnostic laparoscopy due to infertility were recruited, and classified as early-stage endometriosis (n=30), advanced-stage endometriosis (n=8) or no endometriosis (n=31). The frequency and phenotype of leukocytes were evaluated in peritoneal fluid. While the frequency of lymphocytes was not significantly different, neutrophils were increased in endometriosis. Flow cytometry analysis revealed an increased frequency of CD4(+) and CD8(+) cells in peritoneal fluid of endometriosis patients. In addition, the frequency of CD4(+)CD25(+)CD103(+) cells and lineage(-)HLA-DR(+)CD11c(+)CD123(+) dendritic cells was decreased in peritoneal fluid in endometriosis, whereas CD57(+) NK cells and CD8(+)CD28(-) T suppressor cells remained largely unaltered. We conclude that therapeutic approaches in endometriosis might focus on peritoneal leukocytes as a target or surveillance marker; however, immune alterations in peritoneal fluid are subtle and their analysis will require highly standardized and harmonized protocols.

AB - Endometriosis is a widespread chronic disease characterized by endometrial tissue located outside the uterine cavity. Clinical signs are chronic pelvic pain and infertility. Emerging evidence indicates that the immune system is profoundly involved in the onset and/or progression of endometriosis. However, mechanistic pathways have not yet been conclusively specified. In this study, women undergoing diagnostic laparoscopy due to infertility were recruited, and classified as early-stage endometriosis (n=30), advanced-stage endometriosis (n=8) or no endometriosis (n=31). The frequency and phenotype of leukocytes were evaluated in peritoneal fluid. While the frequency of lymphocytes was not significantly different, neutrophils were increased in endometriosis. Flow cytometry analysis revealed an increased frequency of CD4(+) and CD8(+) cells in peritoneal fluid of endometriosis patients. In addition, the frequency of CD4(+)CD25(+)CD103(+) cells and lineage(-)HLA-DR(+)CD11c(+)CD123(+) dendritic cells was decreased in peritoneal fluid in endometriosis, whereas CD57(+) NK cells and CD8(+)CD28(-) T suppressor cells remained largely unaltered. We conclude that therapeutic approaches in endometriosis might focus on peritoneal leukocytes as a target or surveillance marker; however, immune alterations in peritoneal fluid are subtle and their analysis will require highly standardized and harmonized protocols.

U2 - 10.1016/j.jri.2008.12.005

DO - 10.1016/j.jri.2008.12.005

M3 - SCORING: Zeitschriftenaufsatz

VL - 80

SP - 80

EP - 90

JO - J REPROD IMMUNOL

JF - J REPROD IMMUNOL

SN - 0165-0378

IS - 1-2

M1 - 1-2

ER -